23.08.2023 | ASO Author Reflections
ASO Author Reflections: Breast Cancer-Related Lymphedema (BCRL) Surveillance Recommendations with Bioimpedance Spectroscopy
verfasst von:
Elizabeth J. Jeffers, MD, Jamie L. Wagner, DO, MBA, Lyndsey J. Kilgore, MD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 10/2023
Einloggen, um Zugang zu erhalten
Excerpt
Survivorship is increasingly important as mortality for breast cancer continues to decrease and patients are living longer after breast cancer treatment.
1 Breast cancer-related lymphedema (BCRL) is a significant feared complication of patients after breast cancer treatments.
2 Reported BCRL rates after axillary lymph node dissection (ALND) range up to 58%.
3 Although multiple methods are used to monitor and diagnose BCRL,
4 bioimpedance spectroscopy (BIS) has been shown to identify early fluid shifts consistent with subclinical lymphedema.
2 The authors have previously shown that BIS surveillance facilitating early BCRL diagnosis and early at-home interventions has low persistent BCRL (pBCRL) rates.
5 Guidelines for lymphedema surveillance are commonly based on expert opinion due to limited long-term follow-up data to guide recommenations.
4 …